Medicine & Life Sciences
Protein-Tyrosine Kinases
100%
Acute Myeloid Leukemia
82%
Mutation
55%
lestaurtinib
55%
Leukemia
54%
fms-Like Tyrosine Kinase 3
28%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26%
Hematopoietic Stem Cells
24%
3-tyrosine
21%
Receptor Protein-Tyrosine Kinases
19%
Bone Marrow
18%
Stem Cells
17%
IMC-EB10
15%
Ligands
14%
Drug Therapy
14%
Cell Line
12%
TTT-3002
11%
Nuclear Matrix
11%
Phosphotransferases
11%
Myeloid Cells
11%
Survival
10%
Therapeutics
10%
Genes
10%
6,7-dimethoxy-3-phenylquinoxaline
8%
Phosphorylation
8%
In Vitro Techniques
8%
CCAAT-Enhancer-Binding Proteins
7%
Myeloid Leukemia
7%
Pediatrics
7%
Sorafenib
7%
SCID Mice
6%
Neoplasms
6%
Interleukin-3
6%
Dendritic Cells
6%
Cell Survival
6%
KW 2449
5%
Point Mutation
5%
nuclear pore complex protein 98
5%
Tyrosine
5%
Proteins
5%
DNA
5%
Apoptosis
5%
Chemical Compounds
Mutation
41%
Tyrosine
37%
Tyrosine Kinase Inhibitor
28%
Block Like Crystal
8%
Ligand
5%